ESLAW - Estrella Immunopharma, Inc. Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ESLAW

ESTRELLA IMMUNOPHARMA, INC.

NASDAQ

$0.08

▲ UP 3.33% (0.00)

KEY STATISTICS

Market Cap$24.57 M

52w High$0.11

52w Low$0.07

Dividend Yield—

Frequency—

P/E-0.16

Volume2.18K

Shares Out.35.42M

COMPANY

LEADERSHIP

Cheng Liu

CHIEF EXECUTIVE

Cheng Liu

ABOUT

SECTOR

Healthcare

WENT PUBLIC

October 2, 2023

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

3

UPCOMING EARNINGS

DateDec 2, 2026

DayWednesday

Rev. Est.—

DEC

2

WED

PRICE

$0.08 ▲ UP 3.33% (+$0.00)

About Estrella Immunopharma, Inc.

https://www.estrellabio.com ↗

Estrella Immunopharma, Inc. is a preclinical-stage biotech in California developing T-cell therapies for blood cancers and solid tumors, with lead candidates EB103 and EB104, and a partnership with Imugene for solid tumor treatments.

INDUSTRY

Biotechnology

A PRODUCT ESTRELLA IMMUNOPHARMA, INC. IS KNOWN FOR

EB103

EB103

EB103 is a CD19-targeted ARTEMIS® T-cell therapy in clinical trials for aggressive B-cell Non-Hodgkin Lymphoma, representing Estrella Immunopharma's focus on innovative cancer and autoimmune disease treatments.

COMPETITORS

COMPETITOR

INSTITUTIONAL OWNERSHIP

SHARES OWNED

2.23%

HOLDERS

16

TOP 12 OF 16 · RANKED BY POSITION SIZE

Boothbay Fund Management, LLC

189.9K sh · $201.29K

Atw Spac Management LLC

183.1K sh · $9.48K

D. E. Shaw & Co., Inc.

87.5K sh · $6.13K

Skyview Investment Advisors, LLC

62.5K sh · $5K

Yakira Capital Management, Inc.

46.5K sh · $2.33K

Whitebox Advisors LLC

42.3K sh · $2.12K

Toronto Dominion Bank

35.8K sh · $1.86K

Cowen And Company, LLC

35.6K sh · $2.29K

Clear Street Group Inc.

34.1K sh · $2.55K

Clear Street LLC

34.0K sh · $1.61K

Robertson Stephens Wealth Management, LLC

26.0K sh · $40.56K

Susquehanna International Group, Llp

14.0K sh · $728

RATINGS SNAPSHOT

Overall rating: C+

Discounted Cash Flow4

Return On Equity5

Return On Assets1

Debt To Equity1

Price To Earnings1

Price To Book1

Overall Score2

INSIDER TRADES

★

DIRECTOR, OFFICER: CEO

Liu Cheng

Purchase · 100.0K shares

2026-08-25

★

DIRECTOR, OFFICER: CEO

Liu Cheng

Purchase · 100.0K shares

2026-08-25

★

OFFICER: CHIEF FINANCIAL OFFICER

Xu Jiandong

Purchase · 100.0K shares

2026-08-18

★

OFFICER: CHIEF FINANCIAL OFFICER

Xu Jiandong

Sale · 100.0K shares

2026-08-18

SECTORS PEERS

PEER	PRICE
TVGN	$6.89	COMPARE
BCDA	$1.15	COMPARE
KPRX	$2.62	COMPARE
APRE	$0.84	COMPARE
INAB	$1.03	COMPARE
ACXP	$1.44	COMPARE
MLEC	$6.80	COMPARE
APVO	$2.37	COMPARE